195 related articles for article (PubMed ID: 21855168)
21. Complement fragments C3a and C5a: the salt and pepper of the immune response.
Sacks SH
Eur J Immunol; 2010 Mar; 40(3):668-70. PubMed ID: 20186746
[TBL] [Abstract][Full Text] [Related]
22. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
[TBL] [Abstract][Full Text] [Related]
23. Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.
Vieyra M; Leisman S; Raedler H; Kwan WH; Yang M; Strainic MG; Medof ME; Heeger PS
Am J Pathol; 2011 Aug; 179(2):766-74. PubMed ID: 21704012
[TBL] [Abstract][Full Text] [Related]
24. The role of anaphylatoxins C3a and C5a in regulating innate and adaptive immune responses.
Peng Q; Li K; Sacks SH; Zhou W
Inflamm Allergy Drug Targets; 2009 Jul; 8(3):236-46. PubMed ID: 19601884
[TBL] [Abstract][Full Text] [Related]
25. The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.
Kastl SP; Speidl WS; Kaun C; Rega G; Assadian A; Weiss TW; Valent P; Hagmueller GW; Maurer G; Huber K; Wojta J
J Thromb Haemost; 2006 Aug; 4(8):1790-7. PubMed ID: 16879222
[TBL] [Abstract][Full Text] [Related]
26. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
27. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
28. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-33 Amplifies Human Mast Cell Activities Induced by Complement Anaphylatoxins.
West PW; Bahri R; Garcia-Rodriguez KM; Sweetland G; Wileman G; Shah R; Montero A; Rapley L; Bulfone-Paus S
Front Immunol; 2020; 11():615236. PubMed ID: 33597949
[TBL] [Abstract][Full Text] [Related]
30. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
31. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.
Ali H
Immunol Lett; 2010 Jan; 128(1):36-45. PubMed ID: 19895849
[TBL] [Abstract][Full Text] [Related]
32. Effect of anaphylatoxin C3a, C5a on the tubular epithelial-myofibroblast transdifferentiation in vitro.
Liu F; Gou R; Huang J; Fu P; Chen F; Fan WX; Huang YQ; Zang L; Wu M; Qiu HY; Wei DP
Chin Med J (Engl); 2011 Dec; 124(23):4039-45. PubMed ID: 22340339
[TBL] [Abstract][Full Text] [Related]
33. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells.
Zhang X; Lewkowich IP; Köhl G; Clark JR; Wills-Karp M; Köhl J
J Immunol; 2009 Apr; 182(8):5123-30. PubMed ID: 19342693
[TBL] [Abstract][Full Text] [Related]
34. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
[TBL] [Abstract][Full Text] [Related]
35. The Complement C3a
Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
[TBL] [Abstract][Full Text] [Related]
36. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
[TBL] [Abstract][Full Text] [Related]
37. Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8
Kim SH; Cho BH; Kim KS; Jang YS
Cell Rep; 2021 Apr; 35(2):108995. PubMed ID: 33852847
[TBL] [Abstract][Full Text] [Related]
38. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
39. C5a and C5a(desArg) enhance the susceptibility of monocyte-derived macrophages to HIV infection.
Kacani L; Bánki Z; Zwirner J; Schennach H; Bajtay Z; Erdei A; Stoiber H; Dierich MP
J Immunol; 2001 Mar; 166(5):3410-5. PubMed ID: 11207298
[TBL] [Abstract][Full Text] [Related]
40. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact.
Thangam EB; Venkatesha RT; Zaidi AK; Jordan-Sciutto KL; Goncharov DA; Krymskaya VP; Amrani Y; Panettieri RA; Ali H
FASEB J; 2005 May; 19(7):798-800. PubMed ID: 15758041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
